Dr. Benjamin Markman
Claim this profileMonash Health
Studies Colorectal Cancer
Studies Squamous Cell Carcinoma
3 reported clinical trials
14 drugs studied
Area of expertise
1Colorectal Cancer
Stage IV
RECIST 1.1
Stage III
2Squamous Cell Carcinoma
RECIST 1.1
metastatic
nonsmall cell lung cancer
Clinical Trials Benjamin Markman is currently running
Tucatinib + Trastuzumab + Chemotherapy
for Colorectal Cancer
This study is being done to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive colorectal cancer. This study will also determine what side effects happen when participants take this combination of drugs. A side effect is anything a drug does to the body besides treating your disease. Participants in this study have colorectal cancer that has spread through the body (metastatic) and/or cannot be removed with surgery (unresectable). Participants will be assigned randomly to the tucatinib group or standard of care group. The tucatinib group will get tucatinib, trastuzumab, and mFOLFOX6. The standard of care group will get either: * mFOLFOX6 alone, * mFOLFOX6 with bevacizumab, or * mFOLFOX6 with cetuximab mFOLFOX6 is a combination of multiple drugs. All of the drugs given in this study are used to treat this type of cancer.
Recruiting2 awards Phase 3
Dostarlimab
for Colon Cancer
This trial is testing dostarlimab, a drug that helps the immune system fight cancer. It targets patients with a specific type of colon cancer that has certain genetic features and can be surgically removed. Dostarlimab works by helping the immune system recognize and destroy cancer cells.
Recruiting2 awards Phase 3
More about Benjamin Markman
Clinical Trial Related6 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Benjamin Markman has experience with
- CPI-006
- Ciforadenant
- Pembrolizumab
- Tucatinib
- Trastuzumab
- Fluorouracil
Breakdown of trials Benjamin Markman has run
Colorectal Cancer
Squamous Cell Carcinoma
Non-Hodgkin's Lymphoma
Endometrial Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Benjamin Markman specialize in?
Benjamin Markman focuses on Colorectal Cancer and Squamous Cell Carcinoma. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are RECIST 1.1.
Is Benjamin Markman currently recruiting for clinical trials?
Yes, Benjamin Markman is currently recruiting for 2 clinical trials in Clayton Victoria. If you're interested in participating, you should apply.
Are there any treatments that Benjamin Markman has studied deeply?
Yes, Benjamin Markman has studied treatments such as CPI-006, Ciforadenant, Pembrolizumab.
What is the best way to schedule an appointment with Benjamin Markman?
Apply for one of the trials that Benjamin Markman is conducting.
What is the office address of Benjamin Markman?
The office of Benjamin Markman is located at: Monash Health, Clayton, Victoria 3168 Australia. This is the address for their practice at the Monash Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.